about
Natural product-based nanomedicine: recent advances and issuesChiral mutagenesis of insulin's hidden receptor-binding surface: structure of an allo-isoleucine(A2) analogueEnhancing the Activity of a Protein by Stereospecific Unfolding: CONFORMATIONAL LIFE CYCLE OF INSULIN AND ITS EVOLUTIONARY ORIGINSDesign of an Insulin Analog with Enhanced Receptor Binding Selectivity: RATIONALE, STRUCTURE, AND THERAPEUTIC IMPLICATIONSCrystal structure of a T-cell receptor specific for the human MHC class I homolog MICAAmylin Amyloid Inhibition by Flavonoid Baicalein: Key Roles of Its Vicinal Dihydroxyl Groups of the Catechol Moiety.A Rapid Method for Refolding Cell Surface Receptors and LigandsNatural product-based amyloid inhibitors.Development of Autologous C5 Vaccine Nanoparticles to Reduce Intravascular Hemolysis in Vivo.Diabetes-associated mutations in insulin identify invariant receptor contacts.Diabetes-associated mutations in insulin: consecutive residues in the B chain contact distinct domains of the insulin receptor.How insulin binds: the B-chain alpha-helix contacts the L1 beta-helix of the insulin receptor.Using Thermogenic Beige Cells to Identify Biologically Active Small Molecules and Peptides.Olive Component Oleuropein Promotes β-Cell Insulin Secretion and Protects β-Cells from Amylin Amyloid-Induced Cytotoxicity.Diabetes-associated mutations in human insulin: crystal structure and photo-cross-linking studies of a-chain variant insulin Wakayama.Insights into the Impact of a Membrane-Anchoring Moiety on the Biological Activities of Bivalent Compounds As Potential Neuroprotectants for Alzheimer's Disease.Phytonutrient genistein is a survival factor for pancreatic β-cells via GPR30-mediated mechanism
P50
Q26785633-4DA32AF0-E8E3-4B31-8A10-17E2EB692424Q27638060-53A59690-BF9C-4A26-9E6A-22259463AA85Q27654364-2CCB798B-ABED-4566-BC90-BA778811894FQ27657527-1FA31903-5DC1-4481-9786-E43651DA10CBQ27666700-85596C86-41B6-49C2-AF4F-C2C847355079Q36081058-E4721F69-253F-4573-905B-DA15A93F6874Q36928911-44896811-BD7A-4A67-945E-A6D151D92C7CQ38733078-2D2090C0-A4B0-4A68-A2D0-7B87D7271D4AQ40398444-8EBBC2D1-AB8A-4498-833E-690596F56ED2Q44909475-94387D4A-DA5A-477C-BBEF-AFAA16FBC68CQ44955728-71E147D7-31D4-498B-8700-F960A7581189Q44995090-1AF701F5-6E26-41A1-A7CD-EC770BB46BE0Q45053648-1525FCFE-CADA-4F31-86EE-09D3358CEC4BQ45065779-173D26E7-FFF7-44DD-8258-4A5F537EDCCFQ46407645-E79FF918-6A26-4F49-9FCE-E8C390AF6546Q47899443-F55BA1C4-BC02-4373-A2B5-234AA74200B1Q89050027-77776BCF-928F-4E6E-A8ED-CC43F5835CDF
P50
description
researcher ORCID ID = 0000-0002-0490-9540
@en
name
Bin Xu
@ast
Bin Xu
@en
Bin Xu
@es
Bin Xu
@nl
type
label
Bin Xu
@ast
Bin Xu
@en
Bin Xu
@es
Bin Xu
@nl
prefLabel
Bin Xu
@ast
Bin Xu
@en
Bin Xu
@es
Bin Xu
@nl
P108
P1153
35312992500
57198894960
P31
P496
0000-0002-0490-9540